|
Re: new NSAID specifically targets her2+ breast cancer by decreasing her2 receptor tr
may be the way forward with these nsai drugs is the metronomic approach, taking maybe one tablet each day. Seems like that may keep the beast down but not do too much damage.Just a thought1
Ellie
|